J7517 – Mycophenolate mofetil, oral, 250 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7517
- Long description
- Mycophenolate mofetil, oral, 250 mg
- Short description
- Mycophenolate mofetil oral
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2000
- Last change
- October 1, 2026 – Discontinued
- Termination date
- September 30, 2026
Frequently asked questions
What is HCPCS code J7517?
J7517 is a HCPCS Level II code for mycophenolate mofetil, oral, 250 mg. It was discontinued on September 30, 2026.
Does Medicare cover J7517?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7509 – Methylprednisolone oral, per 4 mg
- J7510 – Prednisolone oral, per 5 mg
- J7511 – Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 – Prednisone, immediate release or delayed release, oral, 1 mg
- J7513 – Daclizumab, parenteral, 25 mg
- J7514 – Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
- J7515 – Cyclosporine, oral, 25 mg
- J7516 – Injection, cyclosporine, 250 mg
- J7518 – Mycophenolic acid, oral, 180 mg
- J7519 – Injection, mycophenolate mofetil, 10 mg
- J7520 – Sirolimus, oral, 1 mg
- J7521 – Tacrolimus, granules, oral suspension, 0.1 mg
- J7524 – Mycophenolate mofetil, oral, 5 mg
- J7525 – Tacrolimus, parenteral, 5 mg
- J7526 – Injection, mycophenolate mofetil, 5 mg
- J7527 – Everolimus, oral, 0.25 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.